Maha Othman – ”BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!”
Maha Othman, Editor-in-Chief of Current Opinion in Hematology Journal, Research Co-Lead at CanVECTOR Research Network, shared on LinkedIn:
”Just returned from my first BIC – and what an experience!
A niche and well-organized conference, BIC 2025 brought together cutting-edge science, rich discussions, and an inspiring community of experts — all set in the beautiful city of Padua.
I had the opportunity to present novel AI-driven data on G14, a potent peptide inhibitor that disrupts the Platelet–VWF interaction.
This research has promising diagnostic and therapeutic potential in PT-VWD and Type 2B VWD; two bleeding disorders.
Proud to share that this collaborative work — between my lab at Queen’s University ’, Thomas Kazmirchuk, Ashkan Golshani Lab at Carleton University — has just been published in Blood Advances.
It was also a pleasure catching up with so many respected colleagues mentors and brilliant minds in the field — Glenn F. Pierce, David Lillicrap, Bernhard Lämmle, Augusto Federici, Cécile Denis, Caterina Casari, Edward Tuddenham, Wolfgang Miesbach …many others and meet rising stars/ make new friends like Gregory Newby, Alexander Tischer and Mathew Auton.
Akso got a chance to see/ experience a glimpse of the fascinating Italian culture , food and architecture Venice, Padua
A special thanks to Flora Peyvandi for decades of research and leadership in this field, and to the BIC organizing committee for the kind invitation.
Always grateful to St. Lawrence College for supporting professional development and quality research.
Thanks to all my students waiting for me to come back to resume our teaching / learning journey and career building!
BIC 2025 is without a doubt a remarkable scientific event — and I’m excited for what lies ahead!”
More from BIC 2025 featured in Hemostasis Today.
-
Jun 9, 2026, 10:52Vaidehi Prasanth: The Role of Viscoelastic Testing in Low- and Middle-Income Countries
-
Jun 9, 2026, 10:37Maria Bruzelius: Hemophilia and Bleeding Disorder in Clinical Practice at NordCoag 2026
-
Jun 9, 2026, 10:02Understanding Factor X Deficiency – ICHCC
-
Jun 9, 2026, 09:49Lee Severin: Why Patients Love Platelet-Rich Plasma
-
Jun 9, 2026, 09:42Lorena Gerlach: Blood Transportation Duty on this Muggy Spring Day
-
Jun 9, 2026, 08:54Shujha Abbas: Understanding the Real Cost of Gene Therapie
-
Jun 9, 2026, 04:47Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
-
Jun 9, 2026, 03:30Fayad Al-Haimus: High-Risk Emergencies and Lifelong Learning at CAEP 2026
-
Jun 9, 2026, 03:14Rucha Patil: A Collaborative Initiative to Transform Rare Blood Disorder Care in Rajasthan